Brains Bioceutical Expands Industry-Leading Cannabinoid Offering with D9-THC and CBN, Unveiling New Frontiers for Drug Development
BSPG Laboratories VANCOUVER, British Columbia, Dec. 16, 2024 (GLOBE NEWSWIRE) — Brains Bioceutical Corp. (Brains Bio), a global leader in natural, GMP-compliant cannabinoid Active Pharmaceutical
Quantexa Recognized as Category Leader in Chartis’ 2024 AML Transaction Monitoring Solutions Report
The data, analytics, and AI software provider achieved “best-in-class” ratings for its anti-money laundering capabilities in data integration, modelling and workflow LONDON, Dec. 16, 2024
FAAM-EUROBAT 2024 Concludes with Groundbreaking Advances in Food Allergy and Anaphylaxis Research
ATHENS, Greece, Dec. 12, 2024 (GLOBE NEWSWIRE) — FAAM-EUROBAT 2024, held from 21-23 November at the InterContinental Athenaeum Athens, brought over 550 attendees from over
Five charts that define the energy transition
China continues to lead in energy transition with low carbon power China total power generation mix, 2015-40 LONDON and HOUSTON and SINGAPORE, Dec. 12, 2024
Five charts that define the energy transition
China continues to lead in energy transition with low carbon power China total power generation mix, 2015-40 LONDON and HOUSTON and SINGAPORE, Dec. 12, 2024
EBC Financial Group Launches US Stocks, Empowering Global CFD Traders to Invest in Top US Companies
EBC brings the US stock market closer to global traders LONDON, Dec. 12, 2024 (GLOBE NEWSWIRE) — EBC Financial Group (EBC) is excited to announce